The Clinical Development Team at Spring Bank is responsible for advancing the clinical programs associated with the company’s innovative SMNH chemistry platform. This team leads the design and execution of clinical trials, ensuring the safety and efficacy of new therapies, particularly in oncology and immunology. By collaborating closely with various stakeholders, the team aims to bring groundbreaking medicines to patients, ultimately enhancing health outcomes globally.
View all